Accessibility settings

This paper is in the following e-collection/theme issue:

Peer-to-Peer Support and Online Communities (839) Use and User Demographics of mHealth (430) Infoveillance, Infodemiology, Digital Disease Surveillance, Infodemic Management (1163) Diabetes (286) Apps, Mobile, Wearables for Diabetes (378) Social Media for Diabetes (41)

Published on in Vol 27 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/66400, first published .
How Glucagon-Like Peptide-1 Medications Are Depicted in Instagram Posts Regarding Women’s Health, Nontraditional Access, and Barriers to Access: Content Analysis

How Glucagon-Like Peptide-1 Medications Are Depicted in Instagram Posts Regarding Women’s Health, Nontraditional Access, and Barriers to Access: Content Analysis

How Glucagon-Like Peptide-1 Medications Are Depicted in Instagram Posts Regarding Women’s Health, Nontraditional Access, and Barriers to Access: Content Analysis

Authors of this article:

Brittnie E Bloom1 Author Orcid Image ;   Marie A Bragg2 Author Orcid Image ;   Melanie R Jay2, 3, 4 Author Orcid Image ;   Daphna Harel5 Author Orcid Image ;   Camile Cline1 Author Orcid Image ;   Matthew Crowe1 Author Orcid Image ;   Avery Montoya1 Author Orcid Image ;   Sandhya Muthuramalingam1 Author Orcid Image ;   Roberto Santana1 Author Orcid Image ;   Stephanie L Albert2 Author Orcid Image
Article Authors Cited by (1) Tweetations Metrics

Journals

  1. Bonfrate L, Caturano A, Conte C. The emerging problem of digital and self misuse of obesity management medications: Protecting their clinical value. European Journal of Clinical Investigation 2026;56(4) View